Abstract: Implementations described herein relate to memory command assignment based on command processor workload. In some implementations, a memory device may determine a first command type of a first memory command. The memory device may identify a first command processor, associated with the first command type, that is one of multiple command processors configured to execute memory commands. The first command processor may be configured to execute only commands having the first command type unless a computational credit condition, associated with another command processor, is satisfied. The memory device may determine that a cumulative computational credit value associated with the first command processor does not satisfy a condition. The memory device may assign the first memory command to the first command processor for execution based on determining that the cumulative computational credit value associated with the first command processor does not satisfy the condition.

Abstract: An embodiment generates an initial set of training data from monitoring data. The initial set of training data is generated by combining outputs from a plurality of pretrained classifiers. The embodiment trains a new classification model using the initial set of training data to identify anomalies in monitoring data. The embodiment performs a multiple-level clustering of the data samples resulting in a plurality of clusters of sub-clusters of data samples, and generates a review list of data samples by selecting a representative data sample from each of the clusters. The embodiment receives an updated data sample from the expert review that includes a revised target classification for at least one of the data samples of the expert review list. The embodiment then trains another replacement classification model using a revised set of training data that includes the updated data sample and associated revised target classification.

Abstract: Methods and compositions for stimulating the growth of hair are disclosed wherein said compositions include a cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compound represented by the formula I wherein the dashed bonds represent the presence or absence of a double bond which can be in the cis or trans configuration and A, B, Z, X, R1 and R2 are as defined in the specification and a penetration enhancer. Such compositions are used in stimulating hair growth of human or non-human animals.

Abstract: Microneedle arrays for introducing an active ingredient through a skin surface of a subject can include a base layer, a plurality of microneedles projecting from the base layer, and an active ingredient. Each of the microneedles comprises an elongate body having a proximal portion and a distal portion, in which the proximal portion is attached to the base layer. Each of the microneedles comprises at least one dissolvable polymer. The active ingredient is incorporated in the elongate body, and the active ingredient is present only in the distal portion and at least internally in the distal portion.

Abstract: Methods for delivery of a biologic agent to the dermis or superficial muscles by topical application of the agent are provided. The methods comprise, in one embodiment, treating or conditioning a skin area to disrupt the stratum corneum in the skin area to define a treated skin area and applying a formulation comprising a biologic agent to the treated skin area.

Abstract: The application provides an automatic verification method and system, with the method executing in a startup procedure of a host electronic device and including: calculating specific to system information to obtain a set of verification values in the startup procedure when the host electronic device is booted up; comparing a verification value from the set of verification values with a preset verification value from a set of preset verification values according to a preset condition and obtaining a comparison result; decapsulating a key to substitute for a step of manually inputting a password when the comparison result indicates conformity; and decrypting the host electronic device with the key to complete the startup procedure. If the system information is desired to be changed, a proxy device is required to re-calculate according to the changed system information to obtain a new set of verification values to substitute the original preset verification values.

Abstract: Methods and compositions for stimulating the growth of hair are disclosed wherein said compositions include a cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compound represented by the formula I wherein the dashed bonds represent the presence or absence of a double bond which can be in the cis or trans configuration and A, B, Z, X, R1 and R2 are as defined in the specification and a penetration enhancer. Such compositions are used in stimulating hair growth of human or non-human animals.

Abstract: A biodegradable film comprising a therapeutically effective amount of a Clostridial neurotoxin is described. Methods for treating rhinitis and for treating a symptom of rhinitis by administering the biodegradable film to the nasal cavity are also described.

Abstract: Microneedle arrays for introducing an active ingredient through a skin surface of a subject can include a base layer, a plurality of microneedles projecting from the base layer, and an active ingredient. Each of the microneedles comprises an elongate body having a proximal portion and a distal portion, in which the proximal portion is attached to the base layer. Each of the microneedles comprises at least one dissolvable polymer. The active ingredient is incorporated in the elongate body, and the active ingredient is present only in the distal portion and at least internally in the distal portion.

Abstract: Microneedle arrays for introducing an active ingredient through a skin surface of a subject can include a base layer, a plurality of microneedles projecting from the base layer, and an active ingredient. Each of the microneedles comprises an elongate body having a proximal portion and a distal portion, in which the proximal portion is attached to the base layer. Each of the microneedles comprises at least one dissolvable polymer. The active ingredient is incorporated in the elongate body, and the active ingredient is present only in the distal portion and at least internally in the distal portion.

Abstract: A topical formulation comprising (a) a therapeutically effective amount of tofacitinib; (b) at least one solvent; and (c) optionally one or more other pharmaceutically acceptable excipients is provided. Also provided is a method for treating and/or preventing autoimmune diseases in a subject administering said topical formulation.

Abstract: Provided is a production process for powdered sugar and liquid syrup, comprising the steps of primary pressing sugar cane juice extraction, three-stage physical filtration, and sugar boiling, wherein the step of the three-stage physical filtration respectively uses a sieve plate, a bagasse separator and a micro-filtration membrane for filtration. The bagasse separator comprises a screen cylinder transversely arranged inside a separation bin. The inlet and outlet of the screen cylinder are respectively connected to a feeding bin and a discharging bin. A juice outlet and a bagasse outlet are respectively provided under the separation bin and the discharging bin. A propeller blade component is provided inside the screen cylinder. The propeller blade component is formed by combining vertical mixing blades with helical blades.

Abstract: Methods and compositions for stimulating the growth of hair are disclosed wherein said compositions include a cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compound represented by the formula I wherein the dashed bonds represent the presence or absence of a double bond which can be in the cis or trans configuration and A, B, Z, X, R1 and R2 are as defined in the specification and a penetration enhancer. Such compositions are used in stimulating hair growth of human or non-human animals.

Abstract: A topical formulation comprising (a) a therapeutically effective amount of tofacitinib; (b) at least one solvent; and (c) optionally one or more other pharmaceutically acceptable excipients is provided. Also provided is a method for treating and/or preventing autoimmune diseases in a subject administering said topical formulation.

Abstract: Provided is a production process for powdered sugar and liquid syrup, comprising the steps of primary pressing sugar cane juice extraction, three-stage physical filtration, and sugar boiling, wherein the step of the three-stage physical filtration respectively uses a sieve plate, a bagasse separator and a micro-filtration membrane for filtration. The bagasse separator comprises a screen cylinder transversely arranged inside a separation bin. The inlet and outlet of the screen cylinder are respectively connected to a feeding bin and a discharging bin. A juice outlet and a bagasse outlet are respectively provided under the separation bin and the discharging bin. A propeller blade component is provided inside the screen cylinder. The propeller blade component is formed by combining vertical mixing blades with helical blades.

Abstract: Methods and compositions for stimulating the growth of hair are disclosed wherein said compositions include a cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compound represented by the formula I wherein the dashed bonds represent the presence or absence of a double bond which can be in the cis or trans configuration and A, B, Z, X, R1 and R2 are as defined in the specification and a penetration enhancer. Such compositions are used in stimulating hair growth of human or non-human animals.

Abstract: The application provides an automatic verification method and system, with the method executing in a startup procedure of a host electronic device and including: calculating specific to system information to obtain a set of verification values in the startup procedure when the host electronic device is booted up; comparing a verification value from the set of verification values with a preset verification value from a set of preset verification values according to a preset condition and obtaining a comparison result; decapsulating a key to substitute for a step of manually inputting a password when the comparison result indicates conformity; and decrypting the host electronic device with the key to complete the startup procedure. If the system information is desired to be changed, a proxy device is required to re-calculate according to the changed system information to obtain a new set of verification values to substitute the original preset verification values.

Abstract: A light guide system for a physiological sensor includes a light channel in optical communication with an emitter and a light channel in optical communication with a detector. The light channels are formed of a bio-compatible resilient plastic, such as a silicone, that is blended with a colorant. Each light channel has an optical transmission spectrum that passes the emitter spectral band and rejects most or all ambient light. The colorant can be a pigment provided as a suspension in a liquid or a dye provided in liquid form. The optical transmission spectrum defines a longpass optical filter where the shortest wavelength of the optical spectrum of the emitter is greater than the transition wavelength of the longpass optical filter. Each of the light channels is configured to be in contact with the skin, thereby reducing or eliminating optical loss due to transmission through an air gap.

Abstract: Methods for delivery of a biologic agent to the dermis or superficial muscles by topical application of the agent are provided. The methods comprise, in one embodiment, treating or conditioning a skin area to disrupt the stratum corneum in the skin area to define a treated skin area and applying a formulation comprising a biologic agent to the treated skin area.